Distribution of the major cytochrome P450 (CYP) 2C9 genetic variants in a Saudi population

Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):111-4. doi: 10.1111/j.1742-7843.2011.00692.x. Epub 2011 Mar 28.

Abstract

Cytochrome P450 (CYP) 2C9 is responsible for the metabolism of a number of widely used drugs such as oral anticoagulants, oral antidiabetics and non-steroidal anti-inflammatory drugs. The CYP2C9 is a genetically polymorphic enzyme. The most common allele is CYP2C9*1, while CYP2C9*2 and CYP2C9*3 are the less-frequent variants. The activity of the enzyme encoded by either CYP2C9 *2 or *3 variant is lower compared with that of the CYP2C9*1. The metabolism of most of the CYP2C9 substrates decreases in varying degrees in subjects carrying the CYP2C9 *2 or *3 allele. The aim of this study was to investigate the frequencies of the major variants of the CYP2C9 in Saudi Arabians.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Cytochrome P-450 CYP2C9
  • Female
  • Genetic Variation*
  • Genetics, Population
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Saudi Arabia
  • Substrate Specificity

Substances

  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases